According to European Commission data, there are more than six million new cases and over 1.8 million cardiovascular disease-related deaths in the EU.
The EU pharmaceutical industry found in a recent report that the COVID-19 pandemic deteriorated the situation of people suffering from cardiovascular diseases and called on policymakers for immediate action across the bloc.
In this event report, EURACTIV will examine the different proposals patients and industry stakeholders suggest for Europe to face its “number one killer”.
The pandemic should be seen as a wake-up call for EU policymakers to take a more focused approach toward cardiovascular diseases (CVD), Europe’s number one killer, as patients have already paid a heavy price due to COVID-19, stakeholders have warned.
EU policymakers should develop a more structured approach to improving cardiovascular diseases if the bloc wants to see tangible results in future healthcare, Dr Charmaine Griffiths, interim president of the European Heart Network (EHN) told EURACTIV in an interview.
In the report we published on “Health Systems After COVID-19” last year, we had suggested that evaluating the impact of a pandemic was going to require significant untangling of events that were still under investigation.